The Martín Villar Haemostasis Awards aim to support scientific excellence and innovation, and to engage both physicians and scientists who are early in their careers in investigating haemophilia and von Willebrand disease.


Beginning with the 2017 edition of the Martin Villar Awards, we are pleased to introduce a new concept for the Awards by providing 1 grant of 50.000 EUR for the best project submitted either in Clinical Research or in Basic Research. We hope this new concept will enhance innovation in the field of Haemostasis research and ultimately lead to benefit in patient care.


Applications are evaluated based on four criteria:

  • Scientific merit
  • Innovation
  • Clinical / medical impact
  • Quality of research environment


Scientists or clinicians up to 40 years of age with an innovative idea relevant to haemophilia and von Willebrand disease pathologies or management with plasma-derived protein therapies are invited to apply for the Martin Villar Award.  Applications are encouraged from either individuals or research teams who are engaged in research at Universities, hospitals, or independent research institutions.


Eligible applicants must submit a CV and a Letter of Intent outlining the aims of their research project.  Application letters that fulfill the terms of entry will be assessed and judged by a Review Committee comprised of five experts from healthcare, research, and industry.  Based on their review, the Committee will invite several candidates to submit a full research proposal.  The Review Committee will evaluate the research proposals and select the award recipient.